GLAND PHARMA LTD FDA Approval ANDA 079224

ANDA 079224

GLAND PHARMA LTD

FDA Drug Application

Application #079224

Application Sponsors

ANDA 079224GLAND PHARMA LTD

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 2MG BASE/ML0ONDANSETRON HYDROCHLORIDEONDANSETRON HYDROCHLORIDE

FDA Submissions

ORIG1AP2009-09-25
LABELING; LabelingSUPPL2AP2013-06-30STANDARD
LABELING; LabelingSUPPL4AP2013-06-30STANDARD
LABELING; LabelingSUPPL5AP2015-01-09STANDARD
LABELING; LabelingSUPPL6AP2015-01-09STANDARD
LABELING; LabelingSUPPL11AP2021-08-18STANDARD
LABELING; LabelingSUPPL17AP2021-08-18STANDARD
LABELING; LabelingSUPPL18AP2022-03-11STANDARD

Submissions Property Types

ORIG1Null42
SUPPL2Null15
SUPPL4Null15
SUPPL5Null7
SUPPL6Null15
SUPPL11Null15
SUPPL17Null7
SUPPL18Null7

TE Codes

001PrescriptionAP

CDER Filings

GLAND PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 79224
            [companyName] => GLAND PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ONDANSETRON HYDROCHLORIDE","activeIngredients":"ONDANSETRON HYDROCHLORIDE","strength":"EQ 2MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ONDANSETRON HYDROCHLORIDE","submission":"ONDANSETRON HYDROCHLORIDE","actionType":"EQ 2MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.